Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements:
(1) | Registration Statement (Form S-8 No. 333-199441), pertaining to Agile Therapeutics, Inc. 2014 Incentive Compensation Plan, |
(2) | Registration Statement (Form S-8 No. 333-205116), pertaining to Agile Therapeutics, Inc. 2014 Incentive Compensation Plan, |
(3) | Registration Statement (Form S-8 No. 333-210045), pertaining to Agile Therapeutics, Inc. 2014 Incentive Compensation Plan, |
(4) | Registration Statement (Form S-8 No. 333-217807), pertaining to Agile Therapeutics, Inc. 2014 Incentive Compensation Plan, |
(5) | Registration Statement (Form S-8 No. 333-228151), pertaining to Agile Therapeutics, Inc. Amended and Restated 2014 Incentive Compensation Plan, |
(6) | Registration Statement (Form S-8 No. 333-232989), pertaining to Agile Therapeutics, Inc. Amended and Restated 2014 Incentive Compensation Plan, |
(7) | Registration Statement (Form S-8 No. 333- 254428), pertaining to Agile Therapeutics, Inc. Amended and Restated 2014 Incentive Compensation Plan (filed on March 18, 2021), |
(8) | Registration Statement (Form S-3 No. 333-249273) of Agile Therapeutics, Inc., |
(9) | Registration Statement (Form S-1 No. 333-264960) of Agile Therapeutics, Inc., |
(10) | Registration Statement (Form S-1MEF No. 333-265959) of Agile Therapeutics, Inc., |
(11) | Registration Statement (Form S-1 No. 333-271249) of Agile Therapeutics, Inc., |
(12) | Registration Statement (Form S-1 No. 333-275995) of Agile Therapeutics, Inc. and |
(13) | Registration Statement (Form S-8 No. 333-272576), pertaining to Agile Therapeutics, Inc. 2023 Equity Incentive Plan |
of our report dated March 28, 2024, with respect to the financial statements of Agile Therapeutics, Inc., included in this Annual Report (Form 10-K) of Agile Therapeutics, Inc. for the year ended December 31, 2023.
/s/ Ernst & Young LLP
Iselin, New Jersey
March 28, 2024